Skip to main content
To KTH's start page To KTH's start page

Tuuli Lappalainen

Professor in Genomics

Genomics is the study of our genetic material - the genome - to increase understanding of what lies behind human diversity. Better understanding of the molecular processes that cause disease improves opportunities to develop new drugs and treatments. Perhaps there are simple ways to prevent disease? 

Tuuli Lappalainen’s research group focuses on how different genetic variants affect the molecular and cellular processes that contribute to disease risk and other human traits. Rather than studying specific diseases, Lappalainen’s research focuses on general patterns of how genetic variants affect molecular and cellular functions.

Their research uses a combination of experimental methods and computational analysis of large human genomics data sets. This is based on readings of different people’s genomes and cellular functions, and combining it with compiled health data. Many projects are based on international research collaborations in the field.

These insights are derived from application of groundbreaking methods, including CRISPR technology and large-scale sequencing. This provides insights of how changes in the genome affect cellular functions.

Belongs to: About KTH
Last changed: Apr 19, 2022
Thordis Arrhenius
Jens H Bardarson
Sonja Monica Berlijn
Anna Björklund
Elias Jarlebring
Tuuli Lappalainen
Jonatan Lenells
Martin Lawoko
Linda Lundström
John Löfblom
Joakim Odqvist
Jimmy Olsson
Atsuto Maki
Gunnar Malm
Mihai Mihaescu
Barbara Noziere
Dirk Pleiter
Oscar Quevedo Teruel
Johan Rockberg
Daniel Söderberg
Eric Tyrode
Rakel Wreland Lindström